Article
23 October 2025 - by Charmaine Girdish, Harsha Mirchandani, Allison Halpren, Rebecca L. Johnson
Patient healthcare costs increase substantially in the six months after a nonfatal firearm injury. We analyze patterns for stakeholders to consider.
Article
11 July 2022 - by Samantha Tomicki, Harsha Mirchandani, Rebecca L. Johnson
Given the medical costs of nonfatal firearm injuries, healthcare stakeholders have an interest in supporting further research to mitigate firearm injury risk
Article
19 February 2021 - by Harsha Mirchandani, Samantha Tomicki, Rebecca Smith, Rebecca L. Johnson, Sally Maraldo, Andrew Yang
We describe significant racial disparities in access to preventive diabetes care.
Article
28 February 2019 - by Zach Hunt, Rebecca L. Johnson, Anders Larson
Article
29 January 2019 - by Zach Hunt, Rebecca L. Johnson, Anders Larson
This article focuses on some of the challenges that Medicaid payers (including states and managed care organizations) face when trying to establish alternative payment models with providers.
Article
05 October 2015 - by Ashlee Mouton Borcan, Josh Collins, Robert M. Damler, Daniel Henry, Rebecca L. Johnson, Aaron S Wright
Milliman and the International Actuarial Association have collaborated on a health microinsurance pricing tool for the microinsurance community.
Article
24 September 2015 - by Christine Ferro, Rebecca L. Johnson
This study analyzes the burden of hepatitis C virus infection for a typical adult population in the United States, emphasizing actual costs and utilization rates for commercial insurers and managed Medicaid players.
Article
02 September 2015 - by Rebecca L. Johnson, Howard Kahn, Catherine M. Murphy-Barron, Robert Parke
A recent growing trend has been to shift insurance (utilization) risk from payers to providers through alternate payment contracts (APCs) in an effort to align financial compensation with performance and financially penalize providers if certain financial and quality thresholds are not met.
Article
19 March 2015 - by Rebecca L. Johnson, Catherine M. Murphy-Barron
Healthcare providers should start thinking about strategies
for defending and gaining market share sooner rather than later.
Article
26 June 2013 - by Gabriela Dieguez, Rebecca L. Johnson, Bruce S. Pyenson
An examination of benefit design and costs for specialty-tier prescription drugs.
